CANTARA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 6.499
EU - Europa 5.976
AS - Asia 3.170
SA - Sud America 548
AF - Africa 206
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.418
Nazione #
US - Stati Uniti d'America 6.382
RU - Federazione Russa 1.341
GB - Regno Unito 1.141
IT - Italia 1.129
SG - Singapore 1.062
CN - Cina 953
IE - Irlanda 733
BR - Brasile 443
SE - Svezia 377
VN - Vietnam 327
DE - Germania 289
FR - Francia 280
HK - Hong Kong 240
UA - Ucraina 229
KR - Corea 173
FI - Finlandia 167
IN - India 123
ZA - Sudafrica 118
NL - Olanda 65
CA - Canada 62
BD - Bangladesh 61
ES - Italia 50
TR - Turchia 48
AR - Argentina 43
PL - Polonia 42
JP - Giappone 37
MX - Messico 28
IQ - Iraq 24
BE - Belgio 23
AT - Austria 22
IR - Iran 22
CI - Costa d'Avorio 21
AU - Australia 15
MA - Marocco 14
CH - Svizzera 13
EG - Egitto 13
CL - Cile 12
CZ - Repubblica Ceca 12
EC - Ecuador 12
SA - Arabia Saudita 11
CO - Colombia 10
JO - Giordania 10
KE - Kenya 10
LT - Lituania 10
PK - Pakistan 10
UZ - Uzbekistan 10
VE - Venezuela 10
GR - Grecia 9
JM - Giamaica 9
DZ - Algeria 8
ID - Indonesia 8
NG - Nigeria 8
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
PH - Filippine 6
RO - Romania 6
CR - Costa Rica 5
BO - Bolivia 4
IL - Israele 4
KZ - Kazakistan 4
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
LU - Lussemburgo 3
NO - Norvegia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IM - Isola di Man 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
Totale 16.407
Città #
Southend 996
Dallas 827
Dublin 720
Fairfield 600
Singapore 570
Ashburn 496
Moscow 401
Santa Clara 370
Chandler 346
San Jose 337
Woodbridge 236
Hong Kong 225
Seattle 225
Hefei 219
Wilmington 216
Beijing 208
Houston 190
Jacksonville 183
Cambridge 176
Siena 171
Seoul 169
Florence 168
Ann Arbor 158
Los Angeles 121
The Dalles 119
New York 112
Ho Chi Minh City 107
Johannesburg 107
Milan 99
Council Bluffs 98
Munich 97
Princeton 90
Lauterbourg 89
Helsinki 84
Hanoi 67
Nanjing 53
São Paulo 51
Rome 49
Shanghai 46
Buffalo 43
San Diego 38
Chicago 37
Poggiomarino 37
Orem 35
Boardman 34
Potenza Picena 33
Bengaluru 32
London 32
Turku 32
Warsaw 32
Redondo Beach 30
San Mateo 30
Montreal 29
Lappeenranta 28
Tokyo 27
Frankfurt am Main 26
Chennai 25
Columbus 24
Dearborn 24
Abidjan 21
Brooklyn 21
Málaga 21
Brussels 20
Lancaster 20
Atlanta 19
Tianjin 19
Stockholm 18
Denver 16
Izmir 16
Nanchang 16
Amsterdam 15
Fremont 15
Redwood City 15
Belo Horizonte 14
Guangzhou 14
Haiphong 14
Manchester 14
Nuremberg 14
Portsmouth 14
Da Nang 13
Düsseldorf 13
Kunming 13
Ravenna 13
Rio de Janeiro 13
San Francisco 13
Shenyang 13
Dong Ket 12
Toronto 12
Turin 12
Vienna 12
Zurich 12
Clifton 11
Curitiba 11
Jiaxing 11
Miami 11
Poplar 11
Washington 11
Boston 10
Brasília 10
Cairo 10
Totale 10.807
Nome #
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 371
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 345
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 319
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 319
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 315
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 299
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 294
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 292
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 279
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 278
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 273
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 266
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 263
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 260
Clinical significance of type 2 iodothyronine deiodinase polymorphism 257
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 254
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 238
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 238
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 237
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 234
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 231
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 221
Gene-related alterations in four male patients with elevated serum gonadotrophins levels 220
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 219
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 218
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 216
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 215
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 214
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 214
BROX haploinsufficiency in familial nonmedullary thyroid cancer 203
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 203
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 201
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 195
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 194
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 193
Mitigation of UV-B Radiation Stress in Tobacco Pollen by Expression of the Tardigrade Damage Suppressor Protein (Dsup) 192
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 191
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 190
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 189
miRNA Targets: From Prediction Tools to Experimental Validation 188
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 187
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 186
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 184
Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress 181
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 181
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 180
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 180
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 179
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 179
Follow-up after bariatric surgery: is it time to tailor it? Analysis of early predictive factors of 3-year weight loss predictors of unsuccess in bariatric patients 179
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 172
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics 172
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 169
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 169
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 168
Telomeres and thyroid cancer 167
Silent thyroiditis following vaccination against COVID-19: report of two cases 163
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 163
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 163
Familial non-medullary thyroid cancer: a critical review 158
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 156
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 155
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade 154
Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer 149
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 145
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 145
HLA class I expression on human platelets is highly variable and correlates with distinct allele group frequencies 144
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 143
Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2) 143
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 142
TAT-BH4 counteracts A beta toxicity on capillary endothelium 136
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 135
null 126
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 121
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 121
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 121
What's Wrong in a Jump? Prediction and Validation of Splice Site Variants 117
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology 116
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 107
The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population 94
Telomerase and the endocrine system. 77
Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update 71
Sex hormone profiles in patients with Torsades de Pointes ventricular tachycardia 69
Expression of the ring ligase PRAJA2 in thyroid cancer 67
null 60
null 36
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 15
Totale 16.679
Categoria #
all - tutte 53.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022866 67 96 59 86 49 43 36 35 39 88 115 153
2022/20231.302 71 151 151 171 101 259 45 81 141 42 43 46
2023/20241.346 45 43 102 72 90 278 441 66 23 26 48 112
2024/20253.018 87 113 344 271 351 203 89 163 307 162 304 624
2025/20266.339 500 854 640 801 1.188 253 749 254 248 354 339 159
Totale 16.679